Endothelial and platelet dysfunction in systemic sclerosis with pulmonary hypertension
PLOS One · 2026
DOI: 10.1371/journal.pone.0357987 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Thamonwan Imerbtham und 10 weiteren Autor:innen. Beteiligte Einrichtung: Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Hypertension, Pulmonary, Blood Platelets, Endothelium, Vascular. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by vasculopathy, inflammation, and fibrosis, in which pulmonary hypertension (PH) is a major cause of mortality. In SSc, the relationship between endothelial and platelet functions with echocardiographic findings have not been evaluated. Here, we evaluated the endothelial and platelet functions in SSc patients with different PH probability and tested their associations with echocardiographic parameters, including the maximal tricuspid regurgitant velocity (TRV max ). Endothelial function was assessed by flow-mediated dilation (FMD) of brachial artery and blood nitrite levels, measured by chemiluminescence method. Platelet activity was measured by light transmission aggregometry in response to stimulation by adenosine diphosphate (ADP) and thrombin receptor–activating peptide-6 (TRAP-6). PH probability was assessed by echocardiography, and PH diagnosis was confirmed by right heart catheterization. SSc patients with PH probability had lower FMD than age-matched controls: FMD decreased from 13.3 ± 3.9% in controls to 5.6 ± 1.7%, 4.6 ± 0.4%, and 3.8 ± 0.4% in SSc patients with low PH probability, intermediate PH probability, and confirmed PH, respectively. SSc patients with PH had higher blood nitrite levels than controls or the patients with low PH probability. TRV max correlated inversely with FMD and positively with platelet aggregation. In multivariable regression analysis, TRAP-6-induced platelet aggregation and FMD were independently associated with TRV max . Furthermore, we demonstrated in two patients that nebulized sodium nitrite transiently reduced TRV max . In conclusion, SSc patients have endothelial dysfunction and increased platelet activity, which exhibits correlation with TRV max .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand.
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
- Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Nathawut Sibmooh
Zitieren
APA
Imerbtham, T., Sriwantana, T., Ngamjanyaporn, P., Sotananusak, T., Ngammisri, P., Trerayapiwat, K., Dumrongkitchaiporn, P., Pisitkun, P., Srihirun, S., Vivithanaporn, P., & Sibmooh, N. (2026). Endothelial and platelet dysfunction in systemic sclerosis with pulmonary hypertension. PLOS One. https://doi.org/10.1371/journal.pone.0357987
Vancouver
Imerbtham T, Sriwantana T, Ngamjanyaporn P, Sotananusak T, Ngammisri P, Trerayapiwat K, et al. Endothelial and platelet dysfunction in systemic sclerosis with pulmonary hypertension. PLOS One. 2026. doi:10.1371/journal.pone.0357987
BibTeX
@article{Imerbtham2026,
author = {Imerbtham, Thamonwan and Sriwantana, Thanaporn and Ngamjanyaporn, Pintip and Sotananusak, Thanyaluck and Ngammisri, Pipat and Trerayapiwat, Krittimeth and Dumrongkitchaiporn, Panu and Pisitkun, Prapaporn and Srihirun, Sirada and Vivithanaporn, Pornpun and Sibmooh, Nathawut},
title = {Endothelial and platelet dysfunction in systemic sclerosis with pulmonary hypertension},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357987}
}
EUVIMED